3 December 2019

The aim of NBCS is to investigate lifestyle factors and genetic factors in relation to the risk of bladder cancer, the course of the disease, and the effect of therapy. The influence of specific characteristics of the bladder tumor itself on the course and effect of therapy is also being studied. The ambition of NBCS is to be able to determine which people are at high risk of developing a bladder tumor and to be able to personalize the treatment of patients with a bladder tumor even better to the individual patient. NBCS consists of questionnaire data, additional information from medical files and existing national health registration systems (cancer registries, registries of death certificates and pathology archives) and biomaterial (DNA, whole blood and tumor tissue).
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud Biobank

Related news items


Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl)

19 July 2022

The Ministry of Health, Welfare and Sport (VWS) is currently preparing a Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl) which will serve in the future as a specific legal framework for the (further) use of body tissue for medical scientific research.

read more

Health-RI annual report

19 July 2022

Health-RI has presented the 2021 annual report. In this report they outline an overview of recent activities and results of the past year 2021 (in Dutch).

read more

SPIDI sub-biobank

19 July 2022

The SPIDI collection aims to assess the prognostic value of MRI-DWI (new form of MRI research) and biomarkers (brain-specific proteins in cerebrospinal fluid) in the first 24 hours after the occurrence of a spinal cord injury as a result of trauma.

read more

MyCoS sub-biobank

8 April 2022 The Radboud Biobank has added one new sub-biobank to the collection: MyCoS. read more